Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk

S Weidinger, H Baurecht, S Wagenpfeil, J Henderson, N Novak, A J Sandilands, H Chen, E Rodriguez, GM O’Regan, R Watson, Y Liao, Y Zhao, JNWN Barker, Marian F Allen, N J Reynolds, S Meggit, K Northstone, G Davey Smith, C Strobl, C StahlT Kneib, N Klopp, T Bieber, H Behrendt, CAN Palmer, H-E Wichmann, J Ring, T Illig, WHI Mclean, AD Irvine

Research output: Contribution to journalArticle (Academic Journal)peer-review

64 Citations (Scopus)
Translated title of the contributionAnalysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk
Original languageEnglish
Pages (from-to)560 - 568
Number of pages9
JournalJournal of Allergy and Clinical Immunology
Volume122
DOIs
Publication statusPublished - Nov 2008

Cite this